SCHEDULE 13D/A

Terns Pharmaceuticals Inc

Common Stock · CUSIP: 880881107

Event date: 2025-11-03

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• ORBIMED ADVISORS LLCReported CIK 0001055951

  Shares: 4,240,068.00 · Class: 4.8%

• ORBIMED CAPITAL GP VII LLCReported CIK 0001760648

  Shares: 2,722,283.00 · Class: 3.1%

• OrbiMed Asia GP III, L.P.Reported CIK 0001841462

  Shares: 1,061,075.00 · Class: 1.2%

• OrbiMed Advisors III LtdReported CIK 0001841537

  Shares: 1,061,075.00 · Class: 1.2%

• OrbiMed Genesis GP LLCReported CIK 0001808744

  Shares: 456,710.00 · Class: 0.5%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.